Saiers Capital’s Pfizer PFE Stock Holding History

Saiers Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-31,444	Closed	-$1.04M	–	133
2015 Q1	$1.04M	Sell	31,444 -5,446	-15%	-$173K	0.8%	32
2014 Q4	$1.09M	Buy	36,890 +26,877	+268%	+$771K	0.34%	61
2014 Q3	$281K	Buy	+10,013	New	+$281K	0.12%	88
2014 Q1	–	Sell	-213,751	Closed	-$6.21M	–	294
2013 Q4	$6.21M	Sell	213,751 -363,946	-63%	-$10.6M	0.36%	18
2013 Q3	$15.7M	Buy	577,697 +530,267	+1,118%	+$14.4M	2.34%	8
2013 Q2	$1.26M	Buy	+47,430	New	+$1.31M	0.14%	108

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Saiers Capital's PFE Position: Q2 2015 in Review

Saiers Capital sold out of Pfizer (PFE) in Q2 2015, closing a stake of 31,444 shares — an estimated $1.04M sold.

Saiers Capital first reported a position in PFE in Q2 2013 and held it in 6 quarters. The position peaked at $15.7M in Q3 2013. 1,886 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

Saiers Capital reported no remaining Pfizer position as of Q2 2015 after selling out during the quarter.
Saiers Capital sold 31,444 Pfizer shares in Q2 2015, an estimated $1.04M.
Saiers Capital first reported a position in Pfizer in Q2 2013 and held it in 6 quarters.
Saiers Capital's Pfizer position peaked at $15.7M in Q3 2013.
1,886 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on Saiers Capital's 13F filing for Q2 2015, filed 11 Aug 2015.